Prudential plc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,594
Closed -$372K 776
2025
Q1
$372K Hold
8,594
﹤0.01% 645
2024
Q4
$483K Buy
+8,594
New +$535K ﹤0.01% 625
2024
Q1
Sell
-7,290
Closed -$539K 799
2023
Q4
$539K Sell
7,290
-16
-0.2% -$1.05K 0.01% 761
2023
Q3
$498K Sell
7,306
-29
-0.4% -$2.46K 0.01% 751
2023
Q2
$689K Sell
7,335
-2
-0% -$156 0.01% 699
2023
Q1
$498K Sell
7,337
-25
-0.3% -$1.61K 0.01% 751
2022
Q4
$364K Buy
+7,362
New +$301K ﹤0.01% 813

Other funds holding EXAS

Prudential plc's EXAS Position: Q2 2025 in Review

Prudential plc sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 8,594 shares — an estimated $372K sold.

Prudential plc first reported a position in EXAS in Q4 2022 and held it in 7 quarters. The position peaked at $689K in Q2 2023. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Prudential plc reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Prudential plc sold 8,594 Exact Sciences shares in Q2 2025, an estimated $372K.
  • Prudential plc first reported a position in Exact Sciences in Q4 2022 and held it in 7 quarters.
  • Prudential plc's Exact Sciences position peaked at $689K in Q2 2023.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Prudential plc's 13F filing for Q2 2025, filed 12 Aug 2025.